MiniArc Study: Long-Term Effectiveness Trial for AMS Sling Systems
MiniArc
Long-Term Effectiveness Trial for AMS Sling Systems
1 other identifier
observational
188
1 country
1
Brief Summary
Multi-center, prospective, single arm study. Qualify patients will receive treatment for stress urinary incontinence by implantation of an AMS Sling System. The study is a long-term evaluation of effectiveness and safety associated with AMS sling systems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2007
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2007
CompletedFirst Submitted
Initial submission to the registry
October 5, 2007
CompletedFirst Posted
Study publicly available on registry
October 10, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2010
CompletedAugust 27, 2010
August 1, 2010
2.9 years
October 5, 2007
August 26, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of long-term effectiveness after implantation of MiniArc sling via qualitative(i.e.UDI-6 and IIQ-7) and quantitative measurement (i.e.pad weight test and cough stress test) in females for treatment of SUI in general post-market use.
2 years
Secondary Outcomes (1)
Evaluation of procedural variables of the implantation,outcomes,and long-term safety.These outcomes will be measured via questionnaires, procedural data, and report of adverse events.
2 years
Interventions
Eligibility Criteria
Females 18 years or older who have confirmed SUI
You may qualify if:
- Females 18 years or older who have confirmed SUI defined as involuntary loss of urine that occurs during physical activity, such as coughing, sneezing, laughing, or exercise.
You may not qualify if:
- Unwilling or unable to sign ICF
- Unable to understand the study or has a history of non-compliance with medical devices
- Contradicted for the implantation surgery due to the following: renal sufficiency, urethral diverticulum, fistula, significant prolapse conditions, pregnant, pelvic cancer, compromise immune system,vulvar pain,blood coagulation disorder, and chronic abscesses
- Pelvic prolapse greater than grade 3
- Is, in the investigator's opinion, otherwise unsuitable for the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
McKay Urology Research
Charlotte, North Carolina, 28207, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Kennelly, MD
McKay Urology Research
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
October 5, 2007
First Posted
October 10, 2007
Study Start
September 1, 2007
Primary Completion
August 1, 2010
Study Completion
November 1, 2010
Last Updated
August 27, 2010
Record last verified: 2010-08